Thursday, January 13, 2022 (HealthDay News)
arthritis You can prevent cats from doing much of what kittens like.But now there is hope: the first treatment to relieve arthritis pain For cats, it is approved by the US Food and Drug Administration.
Sorencia (flunebetomab injection) is the first monoclonal antibody drug approved by the FDA for use in any animal species. Monoclonal antibodies are a type of protein.
The active ingredient in Sorencia is flunebetomab, a cat-specific monoclonal antibody that binds to a protein called nerve growth factor (NGF). pain Regulation. When flunebetamab binds to NGF, pain The signal from reaching the brain, the FDA explained.
“Cat treatment options Osteoarthritis Very limited. Advances in modern veterinary medicine have helped extend the lifespan of many animals, including cats.However, with longer lifespans, the following chronic illnesses occur: Osteoarthritis“. Dr. Stephen Solomon, director of the FDA’s Center for Veterinary Medicine, said.
Zoetis, Inc. Solensia for sale is only available by prescription from a licensed veterinarian. It is given by injection once a month and is based on the weight of the cat.
“Today’s approval is the first treatment option to help provide relief to cats suffering from this condition and may significantly improve quality of life,” Solomon said in a distributor news release. Said. The agency also said it hopes that this approval will expand the research and development of other monoclonal antibody products for treating animal diseases.
The FDA’s approval of Sorencia is based on two studies in which veterinarians evaluated cats before and after treatment, allowing owners to have the ability of cats to jump on furniture, use toilets, and groom themselves. Reported on.
Overall, cats treated with Sorencia performed better than cats not treated with the drug.
The most common side effects seen in cats treated with Sorencia are: vomiting, diarrhea, Injection site pain, Head and neck scab, Dermatitis When itch skin. These effects were relatively mild and there was no need to discontinue treatment, the FDA said.
For more information
ASPCA has more details Common illnesses in cats..
Source: US Food and Drug Administration, News Release, January 13, 2022
Copyright © 2021 Health Day. all rights reserved.
FDA approves monoclonal antibody to treat arthritis in cats
Source link FDA approves monoclonal antibody to treat arthritis in cats